Venlafaxine Hydrochloride
Product Images NDC 68071-2588

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-2588). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2588 3)

Packaging label for Venlafaxine Hydrochloride 75mg extended-release capsules by NuCare Pharmaceuticals, Inc. The bottle contains 30 capsules, indicated for prescription use (Rx Only). The label includes manufacturer details, lot, expiration, serial numbers, and storage instructions at controlled temperatures (68-77°F). Patient instructions for dosage timing are noted but not fully legible.*

FDA Label Image

Figr1 (Figr1)

A chart depicting pharmacokinetic (PK) fold changes and 90% confidence interval recommendations for venlafaxine and its metabolite ODV when coadministered with various interacting drugs. The horizontal axis shows change relative to a reference value, with interacting drugs listed on the left. Recommendations range from avoiding concomitant use to cautious use and monitoring, or no dose adjustment needed.*

FDA Label Image

Figr2 (Figr2)

A pharmacokinetic interaction chart showing fold changes and 90% confidence intervals for various interacting drugs with Venlafaxine Hydrochloride. The chart plots changes in Cmax and AUC relative to a reference value and provides recommendations regarding dose adjustments or clinical significance for each interacting drug including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

FDA Label Image

Figr3 (Figr3)

A scatter plot chart displaying fold change and 90% confidence intervals for the pharmacokinetics (Cmax and AUC) of venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite in special populations. Populations include hepatic impairment, renal hemodialysis, CYP2D6 polymorphism, age over 60 years, and gender differences. Recommendations for dose adjustment are summarized in a table on the left and right of the plot.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure of Venlafaxine Hydrochloride, showing its molecular arrangement with a chiral center, including a methoxyphenyl group and a cyclohexanol moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.